Монийот-131

Sodium Iodide (131I) is a radioactive iodine treatment used in nuclear medicine for thyroid imaging and therapy. Administered orally, it targets thyroid cells for diagnostic or therapeutic purposes. This EU-sourced option supports thyroid health evaluations and related conditions. Safe handling and professional guidance are required.

Sodium Iodide (131I) is primarily used in nuclear medicine for diagnostic imaging and treatment of thyroid-related conditions. It helps assess thyroid function and detect abnormalities like nodules or hyperthyroidism. The radioactive iodine is absorbed by thyroid cells, aiding in both imaging scans and targeted therapy for overactive thyroids or thyroid cancer.

After oral administration, Sodium Iodide (131I) is absorbed by the thyroid gland, where it emits radiation to either highlight thyroid tissue in scans or reduce overactive thyroid cells. Patients may experience temporary changes in thyroid function as the treatment takes effect. The effects are localized to the thyroid, minimizing impact on other body areas.

Sodium Iodide (131I) is a radioactive substance and requires careful handling. Patients should follow healthcare provider instructions to minimize radiation exposure to others. Pregnant or breastfeeding individuals should avoid this treatment. Proper hydration and thyroid function monitoring are typically recommended post-administration.

Certain medications, such as thyroid hormones or antithyroid drugs, may interfere with the effectiveness of Sodium Iodide (131I). Patients should inform their healthcare provider about all medications, supplements, or recent iodine exposure before treatment. Alcohol and specific foods high in iodine may also affect outcomes and should be discussed with a medical professional.